Buy Rating for MiNK Therapeutics Amidst Promising AGENT-797 Progress and Strategic Financial Moves
TipRanksMar 24 21:48 ET
MiNK Therapeutics Analyst Ratings
BenzingaMar 21 11:25 ET
Robert W. Baird Keeps Their Buy Rating on MiNK Therapeutics (INKT)
TipRanksAug 11, 2023 12:16 ET
Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and MiNK Therapeutics (INKT)
TipRanksAug 11, 2023 09:11 ET
HC Wainwright & Co. Reiterates Buy on MiNK Therapeutics, Maintains $10 Price Target
BenzingaAug 10, 2023 12:01 ET
MiNK Therapeutics Analyst Ratings
BenzingaAug 10, 2023 12:01 ET
MiNK Therapeutics (INKT) Gets a Buy From H.C. Wainwright
TipRanksAug 10, 2023 11:15 ET
B.Riley Financial Sticks to Their Buy Rating for MiNK Therapeutics (INKT)
TipRanksMay 18, 2023 22:35 ET
H.C. Wainwright Sticks to Its Buy Rating for MiNK Therapeutics (INKT)
TipRanksMay 18, 2023 11:25 ET
Robert W. Baird Reaffirms Their Buy Rating on MiNK Therapeutics (INKT)
TipRanksMay 15, 2023 06:05 ET
HC Wainwright Adjusts MiNK Therapeutics Price Target to $10 From $7, Maintains Buy Rating
MT NewswiresMay 12, 2023 09:11 ET
B.Riley Financial Keeps Their Buy Rating on MiNK Therapeutics (INKT)
TipRanksMay 12, 2023 07:25 ET
MiNK Therapeutics (INKT) Has a New Rating From H.C. Wainwright
TipRanksMay 12, 2023 06:25 ET
Robert W. Baird Keeps Their Buy Rating on MiNK Therapeutics (INKT)
TipRanksApr 21, 2023 08:08 ET
H.C. Wainwright Keeps Their Buy Rating on MiNK Therapeutics (INKT)
TipRanksApr 19, 2023 06:26 ET
HC Wainwright & Co. Reiterates Buy on MiNK Therapeutics, Maintains $7 Price Target
BenzingaApr 19, 2023 06:24 ET
Evercore ISI Adjusts MiNK Therapeutics' Price Target to $3 From $4, Keeps Outperform Rating
MT NewswiresMar 22, 2023 11:52 ET
Evercore ISI Group Maintains Outperform on MiNK Therapeutics, Lowers Price Target to $3
BenzingaMar 22, 2023 11:35 ET
Analysts' Top Healthcare Picks: X4 Pharmaceuticals (XFOR), MiNK Therapeutics (INKT)
TipRanksMar 22, 2023 06:25 ET
HC Wainwright & Co. Reiterates Buy on MiNK Therapeutics, Maintains $7 Price Target
BenzingaMar 22, 2023 06:22 ET
No Data
No Data